Phase I study of TTC (Taxotere[docetaxel]/Temodar[temozolomide]/Cisplatin) in metastatic melanoma patients.
Phase of Trial: Phase I
Latest Information Update: 27 Jul 2012
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Temozolomide (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- 26 Mar 2010 Actual end date (1 Nov 2007) added as reported by ClinicalTrials.gov.
- 26 Mar 2010 Actual patient number (23) added as reported by ClinicalTrials.gov.
- 26 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.